William Blair Reiterates Revance Therapeutic (RVNC) at Outperform, Sees DAXI as a Blockbuster in the Making, Believes Approval is an Eventuality
Tweet Send to a Friend
William Blair analyst Tim Lugo reiterated an Outperform rating on Revance Therapeutic (NASDAQ: RVNC), following the company's announcement of resubmission ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
